ProCE Banner Activity

ADCs in HER2-Mutated NSCLC

Slideset

Downloadable slideset from a live satellite symposium on the use of antibody–drug conjugates and tyrosine kinase inhibitors  in the management of HER2-mutated non-small-cell lung cancer, including recommendations on managing interstitial lung disease.

Released: September 16, 2024

Expiration: September 15, 2025

Share

Faculty

Egbert F. Smit

Egbert F. Smit, MD, PhD

Professor of Pulmonary Medicine
Department of Pulmonary Diseases
Leiden University Medical Center
Leiden, Netherlands

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.